/Viatris%20Inc%20logo%20on%20building-by%20SSKH-Pictures%20via%20Shutterstock.jpg)
Viatris Inc. (VTRS), with a market cap of $14.13 billion, is a global healthcare company dedicated to providing access to high-quality medicines and healthcare solutions. Headquartered in Canonsburg, Pennsylvania, Viatris is committed to empowering people worldwide to live healthier lives at every stage of life. The company offers a diverse portfolio of prescription medicines, over-the-counter products, and innovative therapeutic solutions, serving patients in many countries.
VTRS shares have underperformed the broader market over the last year. VTRS has gained 13.8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 18.5%. Also, in 2024, Viatris stock rose 9.6%, lower than SPX's 12.1% rise on a YTD basis.